The United Laboratories International Holdings (HKG:3933) reported a 1.5% decline in profit attributable to owners to 2.66 billion yuan for 2024 from 2.70 billion yuan in the previous year, according to a filing with the Hong Kong bourse on Monday.
Basic earnings per share were 1.4639 yuan, a 1.5% decrease from 1.4867 yuan a year ago.
Revenue increased marginally to 13.76 billion yuan from 13.74 billion yuan in the prior year.
The board recommended a final dividend of 0.28 yuan per share and a special dividend of 0.12 yuan per share. Both dividends are subject to shareholders' approval in an upcoming annual general meeting.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。